List of articles with "Intensity Therapeutics"

Intensity Gets Nasdaq Extension

Intensity Gets Nasdaq Extension

United States NASDAQ Intensity Therapeutics Shelton INT230-6
Intensity to Present at SABCS

Intensity to Present at SABCS

United States San Antonio Intensity Therapeutics SABCS INT230-6
Q3 2025 Financials Update

Q3 2025 Financials Update

United States Intensity Therapeutics Shelton INT230-6 INVINCIBLE-4
Intensity Raises $4 Million

Intensity Raises $4 Million

None cancer therapies stock offering Intensity Therapeutics
INT230-6 Clinical Findings

INT230-6 Clinical Findings

None Cancer Treatment Intensity Therapeutics INT230-6
Intensity's Conference Talk

Intensity's Conference Talk

United States New York Intensity Therapeutics INT230-6 H.C. Wainwright
Intensity Reclaims Nasdaq Compliance

Intensity Reclaims Nasdaq Compliance

United States Intensity Therapeutics Shelton Nasdaq Compliance Intratumoral Cancer Therapies
Strong Q2 2025 Update

Strong Q2 2025 Update

United States cancer therapy Intensity Therapeutics Shelton INT230-6
Oncology Innovation Trends

Oncology Innovation Trends

USA Vancouver Oncolytics Biotech Intensity Therapeutics Cellectar
Intensity's Public Offering

Intensity's Public Offering

cancer therapy Public Offering Intensity Therapeutics Shelton
Intensity Offers Stock

Intensity Offers Stock

United States Intensity Therapeutics Shelton INT230-6 INVINCIBLE Study
INT230-6 Efficacy Boost

INT230-6 Efficacy Boost

USA Intensity Therapeutics Shelton INT230-6 Triple-Negative Breast Cancer
INVINCIBLE-3 Study at ASCO

INVINCIBLE-3 Study at ASCO

United States Chicago Intensity Therapeutics INT230-6 INVINCIBLE-3
A Partnership for Hope

A Partnership for Hope

United States Breast Cancer Intensity Therapeutics Shelton Christine Handy
First Quarter Update

First Quarter Update

United States Intensity Therapeutics Shelton INT230-6 INVINCIBLE-4
New Cancer Study in France

New Cancer Study in France

France Intensity Therapeutics SAKK INT230-6 Shelton & Bern
Intensity’s $2.35M Offering

Intensity’s $2.35M Offering

United States Public Offering Intensity Therapeutics Shelton Cancer Trials
Financial Update 2024

Financial Update 2024

USA Cancer Research Intensity Therapeutics Shelton INT230-6
Intensity Continues Trial

Intensity Continues Trial

United States Intensity Therapeutics Shelton INT230-6 INVINCIBLE-3
Major Updates from Intensity

Major Updates from Intensity

United States Cancer Treatment Intensity Therapeutics Shelton INT230-6
Breast Cancer Trials Update

Breast Cancer Trials Update

United States San Antonio Intensity Therapeutics INVINCIBLE-2 SAKK

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.